Abbott Laboratories Q2 Profit Increases, beats estimates

Abbott Laboratories (ABT) revealed earnings for its second quarter that increased from the same period last year and beat the Street estimates.

The company's earnings came in at $2.02 billion, or $1.14 per share. This compares with $1.19 billion, or $0.66 per share, in last year's second quarter.

Excluding items, Abbott Laboratories reported adjusted earnings of $2.54 billion or $1.43 per share for the period.

Analysts on average had expected the company to earn $1.12 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 10.2% to $11.26 billion from $10.22 billion last year.

Abbott Laboratories earnings at a glance (GAAP) :

-Earnings (Q2): $2.02 Bln. vs. $1.19 Bln. last year.
-EPS (Q2): $1.14 vs. $0.66 last year.
-Analyst Estimate: $1.12
-Revenue (Q2): $11.26 Bln vs. $10.22 Bln last year.

Full year EPS guidance: $4.90

For comments and feedback contact: editorial@rttnews.com

Follow RTT